405 related articles for article (PubMed ID: 11133808)
21. Selective promoter usage of the human estrogen receptor-alpha gene and its regulation by estrogen.
Donaghue C; Westley BR; May FE
Mol Endocrinol; 1999 Nov; 13(11):1934-50. PubMed ID: 10551786
[TBL] [Abstract][Full Text] [Related]
22. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
23. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.
Yang X; Ferguson AT; Nass SJ; Phillips DL; Butash KA; Wang SM; Herman JG; Davidson NE
Cancer Res; 2000 Dec; 60(24):6890-4. PubMed ID: 11156387
[TBL] [Abstract][Full Text] [Related]
25. Expression of the human oestrogen receptor-alpha gene is regulated by promoter F in MG-63 osteoblastic cells.
Lambertini E; Penolazzi L; Giordano S; Del Senno L; Piva R
Biochem J; 2003 Jun; 372(Pt 3):831-9. PubMed ID: 12659635
[TBL] [Abstract][Full Text] [Related]
26. [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].
Tang B; Peng ZH; Jiang J
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1545-9. PubMed ID: 16412295
[TBL] [Abstract][Full Text] [Related]
27. Distinct promoter usage of mdm2 gene in human breast cancer.
Okumura N; Saji S; Eguchi H; Nakashima S; Saji S; Hayashi S
Oncol Rep; 2002; 9(3):557-63. PubMed ID: 11956627
[TBL] [Abstract][Full Text] [Related]
28. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence.
Elgort MG; Zou A; Marschke KB; Allegretto EA
Mol Endocrinol; 1996 May; 10(5):477-87. PubMed ID: 8732679
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma.
Weigel RJ; deConinck EC
Cancer Res; 1993 Aug; 53(15):3472-4. PubMed ID: 8339250
[TBL] [Abstract][Full Text] [Related]
30. Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells.
Coutts AS; Leygue E; Murphy LC
J Mol Endocrinol; 1999 Dec; 23(3):325-36. PubMed ID: 10601978
[TBL] [Abstract][Full Text] [Related]
31. [Correlation between the methylation status of Runx3 gene and positive expression of estrogen receptor in breast cancer].
Yan Z; Gao S; Wu X; Liu H
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):240-4. PubMed ID: 25975905
[TBL] [Abstract][Full Text] [Related]
32. Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR.
Maekawa R; Sato S; Okada M; Lee L; Tamura I; Jozaki K; Kajimura T; Asada H; Yamagata Y; Tamura H; Yamamoto S; Sugino N
Mol Endocrinol; 2016 Mar; 30(3):335-47. PubMed ID: 26683811
[TBL] [Abstract][Full Text] [Related]
33. Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach.
Poola I; Koduri S; Chatra S; Clarke R
J Steroid Biochem Mol Biol; 2000 Apr; 72(5):249-58. PubMed ID: 10822014
[TBL] [Abstract][Full Text] [Related]
34. Cloning and functional characterization of PELP1/MNAR promoter.
Mishra SK; Balasenthil S; Nguyen D; Vadlamudi RK
Gene; 2004 Apr; 330():115-22. PubMed ID: 15087130
[TBL] [Abstract][Full Text] [Related]
35. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
[TBL] [Abstract][Full Text] [Related]
36. Variation in use of estrogen receptor-α gene promoters in breast cancer compared by quantification of promoter-specific messenger RNA.
Higuchi T; Gohno T; Nagatomo T; Tokiniwa H; Niwa T; Horiguchi J; Oyama T; Takeyoshi I; Hayashi S
Clin Breast Cancer; 2014 Aug; 14(4):249-57. PubMed ID: 24332559
[TBL] [Abstract][Full Text] [Related]
37. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE
Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728
[TBL] [Abstract][Full Text] [Related]
38. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
Gingras S; Moriggl R; Groner B; Simard J
Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
[TBL] [Abstract][Full Text] [Related]
39. Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines.
Grandien K; Bäckdahl M; Ljunggren O; Gustafsson JA; Berkenstam A
Endocrinology; 1995 May; 136(5):2223-9. PubMed ID: 7720671
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of estrogen receptor variants in prostate cancer cell lines.
Ye Q; Chung LW; Cinar B; Li S; Zhau HE
J Steroid Biochem Mol Biol; 2000 Dec; 75(1):21-31. PubMed ID: 11179905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]